UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

DESTINATION XL GROUP, INC.

(Exact name of Registrant as Specified in Its Charter)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors of Destination XL Group, Inc. (the “Company”) appointed Carmen R. Bauza as a director of the Company on December 17, 2021. Ms. Bauza currently serves as a member of the board of managers of Claire’s Holdings LLC. Most recently, Ms. Bauza served as the Chief Merchandising Officer at Fanatics, Inc. from January 2019 until April 2021. Prior to that, she was the Chief Merchandising Officer at HSN from November 2016 until December 2017 and the Senior Vice President, General Merchandise Manager Consumables, Health and Wellness at Walmart from June 2007 to October 2016. She previously held roles at Bath & Body Works, Five Below and The Walt Disney Company. Ms. Bauza currently serves as a member of the board of trustees at Seton Hill University and as a member of the advisory board of RoundTable Healthcare Partners Council.

Ms. Bauza will serve as a director until the Company’s next annual meeting of stockholders, which is expected to be held in August 2022, at which time she will stand for re-election. Ms. Bauza has not been appointed to serve on any committees at this time. Upon her appointment to the Board, Ms. Bauza was entitled to receive a pro-rated portion of the Company's non-employee director compensation for the fourth quarter of fiscal 2021. As such, she will receive a prorated portion of the quarterly retainer of $30,000.

In connection with Ms. Bauza’s appointment to the Board, the size of the Company’s Board of Directors increased to seven members.

 

Item 7.01 Regulation FD Disclosure.

On December 20, 2021, the Company issued a press release, furnished herewith as Exhibit 99.1, announcing the appointment of Ms.Bauza.
 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.